Multifocal Intraocular Lens x Monovision x Hybrid Monovision After Bilateral Cataract Surgery

November 1, 2015 updated by: Joao Crispim, Federal University of São Paulo

Multifocal Intraocular Lens vs. Monovision vs. Hybrid Monovision After Bilateral Cataract Surgery

To compare refractive outcomes and patient's visual quality after bilateral cataract surgery when implanting multifocal intraocular lens, monofocal with monovision or hybrid monovision.

Study Overview

Detailed Description

The purpose of this study is to evaluate the results in randomized patients that receive bilateral multifocal IOLs, monofocal IOLs with monovision with emmetropia in one eye and 1.50 D of myopia in the other eye, or monofocal IOL in the dominant eye and multifocal IOL in the non-dominant eye, then evaluate visual and refractive outcomes, as well as independence for glasses after bilateral surgery with 1 year of follow up.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • SP
      • Sao Paulo, SP, Brazil
        • Department of Ophthalmology and Visual Sciences from the Federal University of Sao Paulo (UNIFESP)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

48 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Bilateral senile cataracts.
  • Implantation of IOL in the capsular bag;
  • Implants from 10-30 diopter;
  • Potential Visual Acuity in ≥ 0.2 logMAR (20/32, metric scale) after surgery;

Exclusion Criteria:

  • Amblyopia;
  • Single Eye;
  • History of intraocular surgery in the previous year;
  • Sequel to prior ocular trauma;
  • Important Microphthalmia or aniridia;
  • History of damage to the corneal endothelium (chemical burns, herpetic keratitis, corneal guttata);
  • Corneal astigmatism > 1.0 D;
  • IOP ≥ 21 mmHg in standard caliper;
  • Ocular pathology that affects visual function (uveitis, diabetic retinopathy, age-related macular degeneration, macular dystrophy, retinal detachment, glaucoma, optic neuropathy);
  • Pupil > 5 mm or < 2 mm under photopic conditions;
  • Asymmetrical pupils in the eye or between the eyes;
  • Binocular vision absence;
  • Any situation that endangers the implant position in the capsular bag (post-traumatic zonular weakness, pseudoexfoliation, for example);
  • Patient probably need to laser treatment of the retina;
  • Patients whose expectations are unrealistic;
  • Patients whose lifestyle involves high expectations of visual acuity (writer, driver, for example);
  • Patients at risk of not meeting the clinical follow-up requirements (distance of travel difficulties, for example);

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Multifocal IOL
Cataract removal with topical anesthesia and phacoemulsification is performed. At the end, multifocal intraocular lens implantation in both eyes planning for emmetropia complete the intervention.
Phacoemulsification under topical anesthesia with intraocular lens implantation.
Experimental: Monovision
Cataract removal with topical anesthesia and phacoemulsification is performed. At the end, a monofocal intraocular lens implantation planning for emmetropia in one eye (dominant) and a monofocal IOL planning for 1.50 D of myopia in the other eye (non-dominant) complete the intervention.
Phacoemulsification under topical anesthesia with intraocular lens implantation.
Experimental: Hybrid Monovision
Cataract removal with topical anesthesia and phacoemulsification is performed. At the end, a monofocal intraocular lens implantation in the dominant eye and a multifocal IOL in the non-dominant eye complete the intervention.
Phacoemulsification under topical anesthesia with intraocular lens implantation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual acuity
Time Frame: 1 year
Binocular visual acuity in a semi-darkened room without correction to far, intermediate and near using a typical Snellen chart that is frequently used for visual acuity testing.
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Speed reading measure
Time Frame: 1 year
Assessment is performed to measure the speed reading in each group and compare them. Then using a timer to measure how long does it take to read the page. The speed reading is measured in words per minute (WPM).
1 year
Near stereopsis measure
Time Frame: 1 year
Calculate stereopsis in each group and compare them. Stereoacuity is measured using a stereogram in which separate panels are shown to each eye.
1 year
Contrast sensitivity measure
Time Frame: 1 year
Comparison between groups of the contrast sensitivity. Contrast sensitivity function at five spatial frequencies is measured with the validated instrument (Functional Vision Analyzer® (Stereo Optical, Chicago, IL, USA) with best refraction.
1 year
National Eye Institute Visual Functioning Questionnaire - 25 (VFQ-25) questionnaire
Time Frame: 1 year
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Joao Crispim, MD, Post graduated

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2014

Primary Completion (Actual)

September 1, 2015

Study Completion (Actual)

September 1, 2015

Study Registration Dates

First Submitted

October 27, 2015

First Submitted That Met QC Criteria

November 1, 2015

First Posted (Estimate)

November 3, 2015

Study Record Updates

Last Update Posted (Estimate)

November 3, 2015

Last Update Submitted That Met QC Criteria

November 1, 2015

Last Verified

November 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • PresbyIOL

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cataract

Clinical Trials on Cataract surgery with intraocular lens implantation.

3
Subscribe